HLS Therapeutics Inc. (HLS.TO)
CAD 3.62
(0.56%)
CAD 3.62
(0.56%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 65.79 Million USD | -5.98% |
| 2022 | 69.98 Million USD | 12.29% |
| 2021 | 62.32 Million USD | -3.48% |
| 2020 | 64.57 Million USD | 13.57% |
| 2019 | 56.85 Million USD | 11.09% |
| 2018 | 51.18 Million USD | 7.39% |
| 2017 | 47.66 Million USD | 3404.44% |
| 2016 | 1.36 Million USD | -49.27% |
| 2015 | 2.68 Million USD | -42.74% |
| 2014 | 4.68 Million USD | 4.4% |
| 2013 | 4.48 Million USD | 42.54% |
| 2012 | 3.14 Million USD | -23.9% |
| 2011 | 4.13 Million USD | -66.78% |
| 2010 | 12.44 Million USD | 88.35% |
| 2009 | 6.6 Million USD | 56.7% |
| 2008 | 4.21 Million USD | -37.37% |
| 2007 | 6.73 Million USD | 270.32% |
| 2006 | 1.81 Million USD | -26.64% |
| 2005 | 2.47 Million USD | -32.27% |
| 2004 | 3.65 Million USD | -5.32% |
| 2003 | 3.86 Million USD | 81.49% |
| 2002 | 2.12 Million USD | -4.43% |
| 2001 | 2.22 Million USD | -13.3% |
| 2000 | 2.56 Million USD | -9.23% |
| 1999 | 2.83 Million USD | 81.49% |
| 1998 | 1.55 Million USD | 148.0% |
| 1997 | 628.93 Thousand USD | 69.53% |
| 1996 | 370.97 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 14.24 Million USD | 0.52% |
| 2024 Q1 | 14.16 Million USD | -1.86% |
| 2023 FY | 65.79 Million USD | -5.98% |
| 2023 Q1 | 16.49 Million USD | -9.67% |
| 2023 Q2 | 17.63 Million USD | 6.91% |
| 2023 Q3 | 17.22 Million USD | -2.33% |
| 2023 Q4 | 14.43 Million USD | -16.2% |
| 2022 Q1 | 16.48 Million USD | -2.78% |
| 2022 FY | 69.98 Million USD | 12.29% |
| 2022 Q3 | 17.29 Million USD | -3.62% |
| 2022 Q2 | 17.93 Million USD | 8.79% |
| 2022 Q4 | 18.26 Million USD | 5.64% |
| 2021 Q3 | 14.21 Million USD | -2.36% |
| 2021 Q1 | 16.58 Million USD | -12.15% |
| 2021 FY | 62.32 Million USD | -3.48% |
| 2021 Q2 | 14.55 Million USD | -12.22% |
| 2021 Q4 | 16.96 Million USD | 19.3% |
| 2020 Q3 | 14.05 Million USD | -13.41% |
| 2020 Q4 | 18.88 Million USD | 34.3% |
| 2020 Q2 | 16.23 Million USD | 5.45% |
| 2020 FY | 64.57 Million USD | 13.57% |
| 2020 Q1 | 15.39 Million USD | -6.14% |
| 2019 Q1 | 13.24 Million USD | -1.59% |
| 2019 Q2 | 13.57 Million USD | 2.48% |
| 2019 FY | 56.85 Million USD | 11.09% |
| 2019 Q4 | 16.4 Million USD | 20.3% |
| 2019 Q3 | 13.63 Million USD | 0.49% |
| 2018 Q2 | 12.98 Million USD | 6.2% |
| 2018 FY | 51.18 Million USD | 7.39% |
| 2018 Q4 | 13.45 Million USD | 7.59% |
| 2018 Q3 | 12.5 Million USD | -3.69% |
| 2018 Q1 | 12.22 Million USD | -73.61% |
| 2017 Q1 | 412.42 Thousand USD | 37.25% |
| 2017 FY | 47.66 Million USD | 3404.44% |
| 2017 Q4 | 46.33 Million USD | 9776.97% |
| 2017 Q3 | 469.15 Thousand USD | 19.88% |
| 2017 Q2 | 391.36 Thousand USD | -5.1% |
| 2016 Q3 | 301.95 Thousand USD | -15.99% |
| 2016 FY | 1.36 Million USD | -49.27% |
| 2016 Q2 | 359.41 Thousand USD | -12.14% |
| 2016 Q1 | 409.07 Thousand USD | 4.44% |
| 2016 Q4 | 300.5 Thousand USD | -0.48% |
| 2015 Q2 | 567.94 Thousand USD | -53.43% |
| 2015 Q3 | 612.29 Thousand USD | 7.81% |
| 2015 Q4 | 391.7 Thousand USD | -36.03% |
| 2015 FY | 2.68 Million USD | -42.74% |
| 2015 Q1 | 1.21 Million USD | 9.87% |
| 2014 FY | 4.68 Million USD | 4.4% |
| 2014 Q4 | 1.1 Million USD | 0.63% |
| 2014 Q1 | 1.35 Million USD | 14.36% |
| 2014 Q2 | 1.18 Million USD | -12.48% |
| 2014 Q3 | 1.1 Million USD | -6.76% |
| 2013 Q3 | 1.05 Million USD | 0.42% |
| 2013 Q1 | 1.2 Million USD | 504.44% |
| 2013 FY | 4.48 Million USD | 42.54% |
| 2013 Q4 | 1.18 Million USD | 12.47% |
| 2013 Q2 | 1.04 Million USD | -12.87% |
| 2012 Q4 | -296.96 Thousand USD | -127.37% |
| 2012 FY | 3.14 Million USD | -23.9% |
| 2012 Q3 | 1.08 Million USD | -7.8% |
| 2012 Q2 | 1.17 Million USD | 4.46% |
| 2012 Q1 | 1.12 Million USD | 175.69% |
| 2011 Q1 | 1.08 Million USD | -84.59% |
| 2011 Q2 | 1.38 Million USD | 27.77% |
| 2011 Q3 | 1.41 Million USD | 2.24% |
| 2011 Q4 | 408.63 Thousand USD | -71.15% |
| 2011 FY | 4.13 Million USD | -66.78% |
| 2010 Q2 | 1.95 Million USD | 36.29% |
| 2010 FY | 12.44 Million USD | 88.35% |
| 2010 Q1 | 1.43 Million USD | -1.61% |
| 2010 Q4 | 7.03 Million USD | 256.27% |
| 2010 Q3 | 1.97 Million USD | 1.12% |
| 2009 Q3 | 1.71 Million USD | -16.08% |
| 2009 Q2 | 2.04 Million USD | 32135.03% |
| 2009 FY | 6.6 Million USD | 56.7% |
| 2009 Q4 | 1.45 Million USD | -15.01% |
| 2009 Q1 | 6335.63 USD | 100.54% |
| 2008 FY | 4.21 Million USD | -37.37% |
| 2008 Q4 | -1.16 Million USD | -158.1% |
| 2008 Q3 | 2 Million USD | -3.58% |
| 2008 Q2 | 2.07 Million USD | 46.77% |
| 2008 Q1 | 1.41 Million USD | -16.33% |
| 2007 Q1 | 1.48 Million USD | 256.84% |
| 2007 FY | 6.73 Million USD | 270.32% |
| 2007 Q4 | 1.69 Million USD | 1.62% |
| 2007 Q3 | 1.66 Million USD | 8.47% |
| 2007 Q2 | 1.53 Million USD | 3.38% |
| 2006 Q1 | 435.75 Thousand USD | -45.99% |
| 2006 Q2 | 488.24 Thousand USD | 12.05% |
| 2006 Q3 | 463.01 Thousand USD | -5.17% |
| 2006 Q4 | 416.37 Thousand USD | -10.07% |
| 2006 FY | 1.81 Million USD | -26.64% |
| 2005 Q2 | 508.55 Thousand USD | 16.08% |
| 2005 Q3 | 669.16 Thousand USD | 31.58% |
| 2005 Q4 | 806.86 Thousand USD | 20.58% |
| 2005 Q1 | 438.12 Thousand USD | -45.99% |
| 2005 FY | 2.47 Million USD | -32.27% |
| 2004 Q3 | 890.42 Thousand USD | -7.84% |
| 2004 Q4 | 811.16 Thousand USD | -8.9% |
| 2004 FY | 3.65 Million USD | -5.32% |
| 2004 Q1 | 887.72 Thousand USD | -14.86% |
| 2004 Q2 | 966.12 Thousand USD | 8.83% |
| 2003 Q1 | 741.7 Thousand USD | 40.86% |
| 2003 FY | 3.86 Million USD | 81.49% |
| 2003 Q4 | 1.04 Million USD | -3.88% |
| 2003 Q3 | 1.08 Million USD | 15.97% |
| 2003 Q2 | 935.32 Thousand USD | 26.1% |
| 2002 FY | 2.12 Million USD | -4.43% |
| 2002 Q4 | 526.56 Thousand USD | -2.21% |
| 2002 Q3 | 538.46 Thousand USD | -3.13% |
| 2002 Q2 | 555.88 Thousand USD | 4.82% |
| 2002 Q1 | 530.32 Thousand USD | 4.13% |
| 2001 Q1 | 564.55 Thousand USD | 143.45% |
| 2001 FY | 2.22 Million USD | -13.3% |
| 2001 Q4 | 509.29 Thousand USD | -11.73% |
| 2001 Q3 | 576.95 Thousand USD | -4.1% |
| 2001 Q2 | 601.61 Thousand USD | 6.56% |
| 2000 Q2 | 810.18 Thousand USD | -1.93% |
| 2000 Q1 | 826.13 Thousand USD | -10.61% |
| 2000 FY | 2.56 Million USD | -9.23% |
| 2000 Q4 | 231.89 Thousand USD | -68.67% |
| 2000 Q3 | 740.14 Thousand USD | -8.64% |
| 1999 Q4 | 924.19 Thousand USD | -3.06% |
| 1999 Q2 | 542.67 Thousand USD | 36.48% |
| 1999 Q1 | 397.61 Thousand USD | 26.2% |
| 1999 FY | 2.83 Million USD | 81.49% |
| 1999 Q3 | 953.32 Thousand USD | 75.67% |
| 1998 FY | 1.55 Million USD | 148.0% |
| 1998 Q4 | 315.08 Thousand USD | -19.84% |
| 1998 Q2 | 476.48 Thousand USD | 12.73% |
| 1998 Q1 | 422.68 Thousand USD | 0.0% |
| 1998 Q3 | 393.05 Thousand USD | -17.51% |
| 1997 Q3 | 993.61 Thousand USD | -2.21% |
| 1997 FY | 628.93 Thousand USD | 69.53% |
| 1997 Q2 | 1.01 Million USD | 9.26% |
| 1997 Q1 | 929.89 Thousand USD | 0.0% |
| 1996 FY | 370.97 Thousand USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Aurora Cannabis Inc. | 158.53 Million CAD | 58.497% |
| Avicanna Inc. | 14.59 Million CAD | -350.934% |
| Avant Brands Inc. | 5.65 Million CAD | -1062.732% |
| Cardiol Therapeutics Inc. | 29.53 Million CAD | -122.767% |
| Crescita Therapeutics Inc. | 12.32 Million CAD | -434.083% |
| Knight Therapeutics Inc. | 155.54 Million CAD | 57.697% |
| MediPharm Labs Corp. | 23.08 Million CAD | -185.054% |
| OrganiGram Holdings Inc. | 277.81 Million CAD | 76.315% |
| Canopy Growth Corporation | 308.61 Million CAD | 78.679% |
| Willow Biosciences Inc. | 7.55 Million CAD | -771.048% |
| Auxly Cannabis Group Inc. | 40.28 Million CAD | -63.346% |